Drug Profile
ND 1251
Alternative Names: Phosphodiesterase IV inhibitors - Evotec SELatest Information Update: 25 Sep 2019
Price :
$50
*
At a glance
- Originator Evotec AG
- Developer Evotec SE
- Class Antidepressants
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 22 Feb 2010 Discontinued - Phase-I for Depression in France (PO)
- 29 Mar 2007 Neuro3d has been acquired and merged into Evotec AG
- 31 Mar 2004 Phase-I clinical trials in Depression in France (PO)